Somatic Symptom Disorder
Somatic symptom disorder involves a person having a significant focus on physical symptoms, such as pain, weakness or shortness of breath, that results in major distress and/or problems functioning. The individual has excessive thoughts, feelings and behaviors relating to the physical symptoms.
Cluster Number:
Wiki Number: PW210
Diagnosis: Somatic Symptom Disorder
US Patients:
World Patients:
Sex Ratio:
Age Onset: adolescence
Brain Area:
Symptoms: medical problems, not explained by medicalcause, with excessive worry about the conditions, false pregnancies, mass hysteria,
Progression: psychogenic urinary retention
Causes:
Medications: antidepressants
Therapies: CBT may help reduce stress, cope with preoccupation with symptoms, physical symptoms, depression, improve quality of life
Youtube Video: Body Talk: Stories of Somatization
Amazon or Library Book: The Body Keeps Score
Click the book to link or order from Amazon.
Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,
Section 12.07.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Vortioxetine as an alternative treatment for somatic symptom disorder: case reportby Naoki Furutani on November 22, 2024
Somatic symptom disorder (SSD) is characterized by persistent physical symptoms that cause significant distress and functional impairment. Despite the widespread use of serotonin reuptake inhibitors (SRIs) in treating SSD, some patients experience insufficient response, necessitating alternative therapeutic approaches. We report two cases of SSD that demonstrated significant improvement with vortioxetine, a novel antidepressant with multimodal serotonergic receptor activity. In Case 1, an...
- Measurement Properties of the Patient Health Questionnaire-15 and Somatic Symptom Scale-8: A Systematic Review and Meta-Analysisby Jonna Hybelius on November 20, 2024
CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis, findings supported use of the PHQ-15 and SSS-8 for the assessment of symptom burden, but users should be aware of the complex, multifactorial structures of these scales. More evidence is needed concerning longitudinal measurement properties.
- The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSDby Kelley C O'Donnell on November 19, 2024
Results from multiple recent studies support further evaluation of 3,4-methylenedioxymethamphetamine (MDMA) in conjunction with psychotherapy (i.e., MDMA-Assisted Therapy) in the treatment of post-traumatic stress disorder (PTSD). In two Phase 3 trials, MDMA-Assisted Therapy comprised a short-term, intensive psychotherapy that included three sessions directly facilitated by MDMA (referred to as "experimental sessions"), as well as a number of non-drug psychotherapy sessions. This treatment model...
- Mental Health Stigma and Mental Health Literacy in Russia: Their Prevalence and Associations with Somatic, Anxiety, and Depressive Symptomsby Alena Zolotareva on November 18, 2024
CONCLUSION: This study highlighted the obvious need for measures to reduce mental health stigma and improve mental health literacy in Russian society. In general, these measures can contribute to the promotion of better mental health in Russia.